Product
STN1010904 ophthalmic suspension
1 clinical trial
1 indication
Indication
Fuchs Endothelial Corneal DystrophyClinical trial
A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM StudyStatus: Recruiting, Estimated PCD: 2025-03-01